COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2231: Articles 22301-22310  | Next

Remdesivir for the treatment of COVID-19: A living systematic review
Verdugo-Paiva, F., Acuna, M. P., Sola, I., Rada, G.
10.1101/2020.09.27.20202754 — Posted: 2020-09-28
A Systematic Review and Meta-analysis of Pregnancy and COVID-19: Signs and Symptoms, Laboratory Tests and Perinatal Outcomes
Hassanipour, S., Bagheri Faradonbeh, S., Momeni, K., Heidarifard, Z., Khosousi, M.-J., Khosousi, L., Ameri, H., Arab-Zozani, M.
10.1101/2020.09.28.20202945 — Posted: 2020-09-28
Clinical Course And Risk Factors For In-hospital Death In Critical COVID-19 In Wuhan, China
Li, F., Cai, Y., Gao, C., Zhou, L., Chen, R., Zhang, K., Li, W., Zhang, R., Zhang, X., Wang, D., Liu, Y., Tao, L.
10.1101/2020.09.26.20189522 — Posted: 2020-09-28
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana
Flamand, C., Enfissi, A., Bailly, S., ALVES SARMENTO, C., Beillard, E., Gaillet, M., Michaud, C., Servas, V., Clement, N., Perilhou, A., Carage, T., Musso, D., Carod, J.-F., Eustache, S., Tourbillon, C., Boizon, E., James, S., Djossou, F., Salje, H., Cauchemez, S., Rousset, D.
10.1101/2020.09.27.20202465 — Posted: 2020-09-28 Discussion: Onsite
SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes
Davanzo, G. G., Codo, A. C., Brunetti, N. S., Boldrini, V. O., Knittel, T. L., Monterio, L. B., de Moraes, D., Ferrari, A. J. R., de Souza, G. F., Muraro, S. P., Profeta, G. . S., Wassano, N. S., Santos, L. N., Carregari, V. . C., Dias, A. . H. S., Virgilio-da-Silva, J. V., Castro, I., Silva-Costa, L. . C., Palma, A., Mansour, E., Ulaf, R. G., Bernardes, A. F., Nunes, T. A., Ribeiro, L. C., Agrela, M. V., Moretti, M. L., Buscaratti, L. I., Crunfli, F., Ludwig, R. . G., Gerhardt, J. A., Seste-Costa, R., Forato, J., Amorin, M. . R., Texeira, D. A. T., Parise, P. L., Martini, M. C., Bispo-dos-Santos, K., Simeoni, C. L., Granja, F., Silvestrini, V. C., de Oliveira, E. B., Faca, V. M., Carvalho, M., Castelucci, B. G., Pereira, A. B., Coimbra, L. D., Rodrigues, P. B., Gomes, A. B. S. P., Pereira, F. B., Santos, L. M. B., Sposito, A. C., Carvalho, R. F., Vieira, A. S., Vinolo, M. A. R., Damasio, A., Velloso, L. A., Nakaya, H. I., Marques-Souza, H., Marques, R. E., Martins-de-Souza, D., Skaf, M. S., Proenca-Modena, J. L., Moraes-Vieira, P. M., Mori, M. A., Farias, A. S.
10.1101/2020.09.25.20200329 — Posted: 2020-09-28
Trajectory of COVID-19 epidemic in Europe
Colombo, M., Mellor, J., Colhoun, H. M., M. Gomes, M. G., McKeigue, P. M.
10.1101/2020.09.26.20202267 — Posted: 2020-09-28 Discussion: Onsite
Excess Risk of COVID-19 to University Populations Resulting from In-Person Sporting Events
Johnson, S. S., Jackson, K. C., Mietchen, M. S., Sbai, S., Schwartz, E. J., Lofgren, E.
10.1101/2020.09.27.20202499 — Posted: 2020-09-28
Sleep apnoea is a risk factor for severe COVID-19
Strausz, S., Kiiskinen, T., Broberg, M., Ruotsalainen, S., Koskela, J., Bachour, A., Palotie, A., Palotie, T., Ripatti, S., Ollila, H. M.
10.1101/2020.09.26.20202051 — Posted: 2020-09-28 Discussion: Onsite
Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide
Noh, J., Danuser, G.
10.1101/2020.09.26.20202382 — Posted: 2020-09-28
Comparison of mental health service activity before and shortly after UK social distancing responses to the COVID-19 pandemic: February-March 2020
Stewart, R., Martin, E., Bakolis, I., Broadbent, M., Byrne, N., Landau, S.
10.1101/2020.09.26.20202150 — Posted: 2020-09-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).